N-(3-(QUINOXALIN-6-YLAMINO)PHENYL)ALKANE-SULFONAMIDE DERIVATIVES AS B-RAF KINASE INHIBITORS FOR TREATING CANCER

wherein L is NR8 or O; R1, R2, R3, R4, R5, R6 and R7 are defined herein. Compounds of formula (I) are useful for inhibition of protein kinases. Methods of using compounds of formula (I), stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagno...

Full description

Saved in:
Bibliographic Details
Main Authors YEN, Shih-Chieh, PENG, Shao-zheng, KUO, Mann-Yan, LIAO, Chu-bin, LIN, Nan-horng
Format Patent
LanguageEnglish
French
German
Published 20.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract wherein L is NR8 or O; R1, R2, R3, R4, R5, R6 and R7 are defined herein. Compounds of formula (I) are useful for inhibition of protein kinases. Methods of using compounds of formula (I), stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed
AbstractList wherein L is NR8 or O; R1, R2, R3, R4, R5, R6 and R7 are defined herein. Compounds of formula (I) are useful for inhibition of protein kinases. Methods of using compounds of formula (I), stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed
Author YEN, Shih-Chieh
LIAO, Chu-bin
KUO, Mann-Yan
LIN, Nan-horng
PENG, Shao-zheng
Author_xml – fullname: YEN, Shih-Chieh
– fullname: PENG, Shao-zheng
– fullname: KUO, Mann-Yan
– fullname: LIAO, Chu-bin
– fullname: LIN, Nan-horng
BookMark eNqNirsOgkAQACm08PUPW0JxiYQEY7nAIhfPPbwDIhUh5qwMkOD_Rwo_wGoymdl6q2Ec3MYbWfiR8O-1ZP1AJVnEolV4WzQoC-JWBaiuyCRsrXLNS8kIMjKywUo2ZAEtJMJgDlfJaAkkFzKRlTYWcm2gMrSMfIEUOSWz99av_j27w487D3Kq0kK4aezcPPVPN7hPR2UUxuf4dEzC6I_lC1m4OJU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate N-(3-(QUINOXALIN-6-YLAMINO)PHENYL)ALKAN-SULFONAMID-DERIVATE ALS B-RAF KINASE INHIBITOREN ZUR BEHANDLUNG VON KREBS
DÉRIVÉS SULFONAMIDES DE N-(3-(QUINOXALIN-6-YLAMINO)PHÉNYL)ALKANE EN TANT QU'INHIBITEURS DE LA KINASE B-RAF POUR LE TRAITEMENT DU CANCER
ExternalDocumentID EP3169670B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3169670B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:56:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3169670B13
Notes Application Number: EP20150822821
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211020&DB=EPODOC&CC=EP&NR=3169670B1
ParticipantIDs epo_espacenet_EP3169670B1
PublicationCentury 2000
PublicationDate 20211020
PublicationDateYYYYMMDD 2021-10-20
PublicationDate_xml – month: 10
  year: 2021
  text: 20211020
  day: 20
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies DCB-USA LLC
Development Center for Biotechnology
RelatedCompanies_xml – name: Development Center for Biotechnology
– name: DCB-USA LLC
Score 3.3653793
Snippet wherein L is NR8 or O; R1, R2, R3, R4, R5, R6 and R7 are defined herein. Compounds of formula (I) are useful for inhibition of protein kinases. Methods of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title N-(3-(QUINOXALIN-6-YLAMINO)PHENYL)ALKANE-SULFONAMIDE DERIVATIVES AS B-RAF KINASE INHIBITORS FOR TREATING CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211020&DB=EPODOC&locale=&CC=EP&NR=3169670B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFG8WNepNp8b5lR4M2Q6NDBhkh8UUKIKygsCW7bTAVpJd2OIw_vs-yDa96K1fadqXvP76a98HQo85oHTaz3Mi8oVCNKH0SCZUjSwyOVV6KUB8nYdsyHV3pL1OepMGWu58Yeo4oV91cETQqDnoe1mf1-ufRyy7tq3cPGVLaFo9O8nAlrbsuGIziizZ5oCFgR1YkmVBSeLRQO3qfd2QTSBKh3CLNirrLzY2K6eU9W9Ecc7QUQiTFeU5aoiiiU6sXeK1Jjoebv-7obhVvc0FWnHSVkn7feTxYEJ9jxOdTH06hGondBmf-h3qv1HOSDzynYBDj82wDTxtTBNvzGJMY2ySiDoYGDuNGfa465leEkQxBiqIk4jBQP6CrSpfTXSJsMMSyyWw8tleSjMW7veoXqGDYlWIa4SFEHMtTzVVqHDTULWsr6dzPe9nhpF383TRQq0_p7n5p-8WnVbirk5xRb5DB-XHp7gHeC6zh1qw3xnujEw
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEN4QNOJNUSM-92AaOGyEthR7IKaPra2029oWAifSwjbhUojU-PedNqBe9La7s5nsTjKPbx8zCD1k4KUTNcsIz5YikbnYJymXZLJMu4nYT8DFV3XIPKbYY_l12p_W0Gr_F6bKE_pZJUcEjVqAvheVvd78HGKZ1dvK7WO6gqH1sxUPTWGHjks0I3YFUx_SwDd9QzAMaAksHEo9RVUGXR2A0gFE2E9lmn060ctPKZvfHsU6QYcBMMuLU1TjeRM1jH3htSY68nb33dDcqd72DK0ZaUuk_TZ2mD_VXIcRhcxczYNuJ7Apm7kdzR1pjJJo7Fo-A4pJsQk4baLFzoRGWIuwTkLNwoDYtYhih9mO7sR-GGGAgjgOKUxkL9go69WE5whbNDZsAiuff0tpToPvPUoXqJ6vc36JMOd8IWeJLHEJIg1JTlUlWSiZmg4GWS9Lli3U-pPN1T-0e9SwY8-dw3ZH1-i4FH1p0cXuDaoX7x_8Flx1kd5VQv4C16SPPA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=N-%283-%28QUINOXALIN-6-YLAMINO%29PHENYL%29ALKANE-SULFONAMIDE+DERIVATIVES+AS+B-RAF+KINASE+INHIBITORS+FOR+TREATING+CANCER&rft.inventor=YEN%2C+Shih-Chieh&rft.inventor=PENG%2C+Shao-zheng&rft.inventor=KUO%2C+Mann-Yan&rft.inventor=LIAO%2C+Chu-bin&rft.inventor=LIN%2C+Nan-horng&rft.date=2021-10-20&rft.externalDBID=B1&rft.externalDocID=EP3169670B1